Subtle changes in ligand-receptor interactions dramatically alter transcriptional outcomes of pregnane X receptor...

Area of Science:

• Pharmacology
• Molecular Biology
• Biochemistry

Background:

• Nuclear receptors, like the pregnane X receptor (PXR), regulate gene expression and are targets for disease treatment.
• PXR activation by drugs can alter drug metabolism, affecting efficacy and toxicity.
• Understanding PXR antagonist mechanisms is crucial for developing effective therapeutics.

Purpose of the Study:

• To investigate the molecular mechanisms of PXR antagonists.
• To elucidate how ligand-receptor interactions influence transcriptional outcomes.
• To explore the diversity of PXR ligand activities.

Main Methods:

• Chemical synthesis of structurally similar PXR ligands.
• Assessment of ligand activities (agonist, antagonist, inverse agonist).
• PXR mutation analysis to study structure-activity relationships.
• Investigation of coregulator recruitment dynamics.

Main Results:

• Chemically similar PXR ligands demonstrated distinct agonist, antagonist, and inverse agonist activities.
• Ligand-induced conformational changes in the PXR ligand-binding pocket and coregulator interface were observed.
• PXR mutations modulated ligand activities, highlighting specific amino acid roles.
• Antagonists employed multiple distinct mechanisms for coregulator recruitment.

Conclusions:

• Ligand-PXR interactions are complex, with subtle structural differences leading to diverse functional outcomes.
• The PXR surface and ligand-binding pocket are critical for modulating transcriptional activity.
• Multiple molecular mechanisms underlie PXR antagonism, offering avenues for targeted drug development.